Trial Profile
Study of 1:1 conversion from Prograf((R)) to Advagraf((R)) with or without diltiazem in renal transplant recipients
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Dec 2018
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Transplant rejection
- Focus Pharmacokinetics
- 07 Dec 2018 New trial record
- 23 Nov 2018 Results published in the European Journal of Drug Metabolism and Pharmacokinetics